Magnetic Resonance Imaging Role in Metastatic Liver Disease

Detalhes bibliográficos
Autor(a) principal: Santana,Tomás França de
Data de Publicação: 2024
Outros Autores: Laert,José, Manso,Nuno Lupi, Luersen,Gustavo Felipe, Matos,António Pedro
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://scielo.pt/scielo.php?script=sci_arttext&pid=S2184-06282024000200125
Resumo: Abstract The objective of this study is to provide a comprehensive overview of the utilization of magnetic resonance imaging (MRI) in the identification, characterization, and monitoring of liver metastatic disease, in contrast to alternative imaging modalities, through a bibliographical review and illustrative examples from the author’s clinical practice. The advantages of MRI in this specific context will be explored, emphasizing the utility of hepatospecific contrast agents and the limitations associated with alternative imaging modalities. A comparative analysis of these methods shows that MRI is the most sensitive and specific modality, even more so when using hepatospecific contrast agents, proving to have cost-effectiveness benefits in patient management. It is the authors’ opinion that, provided the technique is available, oncological patient staging where hepatic metastatic disease is a concern should include an abdominal MRI, if possible, with hepatospecific contrast.
id RCAP_a9e27cb23f1433417f19c12134046d09
oai_identifier_str oai:scielo:S2184-06282024000200125
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Magnetic Resonance Imaging Role in Metastatic Liver DiseaseLiver/diagnostic imagingLiver Neoplasms/ diagnostic imagingMagnetic Resonance ImagingAbstract The objective of this study is to provide a comprehensive overview of the utilization of magnetic resonance imaging (MRI) in the identification, characterization, and monitoring of liver metastatic disease, in contrast to alternative imaging modalities, through a bibliographical review and illustrative examples from the author’s clinical practice. The advantages of MRI in this specific context will be explored, emphasizing the utility of hepatospecific contrast agents and the limitations associated with alternative imaging modalities. A comparative analysis of these methods shows that MRI is the most sensitive and specific modality, even more so when using hepatospecific contrast agents, proving to have cost-effectiveness benefits in patient management. It is the authors’ opinion that, provided the technique is available, oncological patient staging where hepatic metastatic disease is a concern should include an abdominal MRI, if possible, with hepatospecific contrast.Círculo Médico2024-06-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S2184-06282024000200125Gazeta Médica v.11 n.2 2024reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S2184-06282024000200125Santana,Tomás França deLaert,JoséManso,Nuno LupiLuersen,Gustavo FelipeMatos,António Pedroinfo:eu-repo/semantics/openAccess2024-11-21T23:00:53Zoai:scielo:S2184-06282024000200125Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-11-21T23:00:53Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Magnetic Resonance Imaging Role in Metastatic Liver Disease
title Magnetic Resonance Imaging Role in Metastatic Liver Disease
spellingShingle Magnetic Resonance Imaging Role in Metastatic Liver Disease
Santana,Tomás França de
Liver/diagnostic imaging
Liver Neoplasms/ diagnostic imaging
Magnetic Resonance Imaging
title_short Magnetic Resonance Imaging Role in Metastatic Liver Disease
title_full Magnetic Resonance Imaging Role in Metastatic Liver Disease
title_fullStr Magnetic Resonance Imaging Role in Metastatic Liver Disease
title_full_unstemmed Magnetic Resonance Imaging Role in Metastatic Liver Disease
title_sort Magnetic Resonance Imaging Role in Metastatic Liver Disease
author Santana,Tomás França de
author_facet Santana,Tomás França de
Laert,José
Manso,Nuno Lupi
Luersen,Gustavo Felipe
Matos,António Pedro
author_role author
author2 Laert,José
Manso,Nuno Lupi
Luersen,Gustavo Felipe
Matos,António Pedro
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Santana,Tomás França de
Laert,José
Manso,Nuno Lupi
Luersen,Gustavo Felipe
Matos,António Pedro
dc.subject.por.fl_str_mv Liver/diagnostic imaging
Liver Neoplasms/ diagnostic imaging
Magnetic Resonance Imaging
topic Liver/diagnostic imaging
Liver Neoplasms/ diagnostic imaging
Magnetic Resonance Imaging
description Abstract The objective of this study is to provide a comprehensive overview of the utilization of magnetic resonance imaging (MRI) in the identification, characterization, and monitoring of liver metastatic disease, in contrast to alternative imaging modalities, through a bibliographical review and illustrative examples from the author’s clinical practice. The advantages of MRI in this specific context will be explored, emphasizing the utility of hepatospecific contrast agents and the limitations associated with alternative imaging modalities. A comparative analysis of these methods shows that MRI is the most sensitive and specific modality, even more so when using hepatospecific contrast agents, proving to have cost-effectiveness benefits in patient management. It is the authors’ opinion that, provided the technique is available, oncological patient staging where hepatic metastatic disease is a concern should include an abdominal MRI, if possible, with hepatospecific contrast.
publishDate 2024
dc.date.none.fl_str_mv 2024-06-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S2184-06282024000200125
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S2184-06282024000200125
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S2184-06282024000200125
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Círculo Médico
publisher.none.fl_str_mv Círculo Médico
dc.source.none.fl_str_mv Gazeta Médica v.11 n.2 2024
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv mluisa.alvim@gmail.com
_version_ 1817549563210235904